Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by Sdmsdmon May 13, 2016 12:09pm
267 Views
Post# 24870557

RE:RE:Some Numbers To Think About

RE:RE:Some Numbers To Think AboutFarmer, your right that there was some confusion regarding the $700k. I think what Dart is saying is that if you assume the company has a 30 day net receivables policy with its customers (I don't think we know?) then its not unreasonable to infer that $700k in sales were made in March. Now there are alot of assumes, ifs and infers in that sentence but its possible. It makes the quarter as a whole look a little unbalanced from a sales perspective but given they were selling primarily to chains in that quarter (with the field force only getting established) its possible it was lumpy. 

I will probably be accused of pumping now but I dont think sales in Q2 of circa $2m is impossible. We now have a sales force selling to the independents and we seem to be gaining traction within some of the larger chains. For example you Canadians seem to love your Sildenafil. :)

Just joking!  GLTA. 






Bullboard Posts